GSK plc’s ledger of settlements and other developments in its defense against Zantac liability complaints got its biggest addition yet on 9 October with the firm’s announcement of settling around 80,000 US state court cases for up to $2.2bn.
In an announcement, the UK pharma also said it also reached an agreement in principle, subject to final approval from the Department of Justice, to pay $70m and resolve a
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?